Skip to main content
. 2023 Jul 3;15(13):3022. doi: 10.3390/nu15133022

Figure 2.

Figure 2

EGCG and metabolic syndrome, target the functioning of the gastrointestinal tract, the liver, the kidneys, and the heart. CVD: cardiovascular diseases and FXR: farnesoid X receptor.